维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="ONDERKA J"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis 显示文摘	Bock F Onderka J Dietrich T	2007	Invest Ophthalmol Vis Sci2007，48，6：	1
	2	Age-related changes in routine limbal lymphatic vessels and corneal lymphangiogenesis显示文摘	Hos D Bachmann B Bock F Onderka J Cursiefen C	2008	Exp Eye Res2008，87，5：	1
	3	Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation显示文摘	Bock F Onderka J Dietrich T	2008	Graefes Arch Clin Exp Ophthalmol2008，246，1：	1
	4	Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis 显示文摘	Bock F Onderka J Dietrich T	2007	Invest Ophthalmol Vis Sci2007，48，6：	1
	5	Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts 显示文摘	Bock F Onderka J Hos D	2008	Exp Eye Res2008，87，5：	1
	6	Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation显示文摘	Bock F Onderka J Dietrich T	2008	Graefes Archive Clinical and Experimental Ophthalmology2008，246，1：	1
	7	B1 ockade of VEGFR3-signal-ling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisati on显示文摘	Bock F Onderka J Dietrich T	2007	GraefesArch Clin Exp Ophthalmol2007，246，1：	1
	8	Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts显示文摘	Bock F Onderka J Hos D	2008	Exp Eye Res2008，87，：	1
	9	Blockade of VEGFR3-signalling specifically inhibis lymphangiogenesis in inflammatory corneal neovas- cularisation显示文摘	Bock F Onderka J Dietrich T	2008	Graefes Areh Clin Exp Opthalmol2008，246，1：	1
	10	Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade 显示文摘	Dietrich T Onderka J Bock F Kruse FE Vossmeyer D Stragies R	2007	Am J Pathol2007，171，1：	1
	11	Genetic heterogeneity of lymphangiogenesis in different mouse strains 显示文摘	Regenfuss B Onderka J Bock F	2010	Am J Pathol2010，177，1：	1
	12	Bevacizumab as a potent ixahibitor of corneal angiogenesis and lymph angiogenesis 显示文摘	BOCK F ONDERKA J DIETRICH T	2007	Invest Ophthamlol Vis Sci2007，48，6：	1
	13	Blockade of VEGFR3-signalling specifically inhibis lymphangiogenesis in inflammatory corneal neovascularisation显示文摘	BOCK F ONDERKA J DIETRICH T		0，，01：	1
	14	Bevacizttmab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangionesis 显示文摘	Bock F Onderka J Dietrich T Bacbmann B Kruse FE Pascbke M	2007	Invest Ophthalmol Vis Sci2007，48，5：	1
	15	Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis显示文摘	Bock F Onderka J Dietrich T	2007	Invest Ophthalmol Vis Sci2007，48，：	1
	16	Thermodynamics and phase stability in the Ga-N system 显示文摘	UNLANDE J ONDERKA B DAVIDOV A	2003	J Cryst Growth2003，256，：	1
	17	Thermodynamics and phase stability in the In-N System 显示文摘	ONDERKA B UNLANDE J SCHMID-FETZER R	2002	J Mater Res2002，17，：	1
	18	bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis显示文摘	Bock F Onderka J Dietrich T Bachmann B Kruse FE Paschke M		0，，：	1
	19	Inflammatory corneal (lymph) angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation显示文摘	Hos D Bock F Dietrich T Onderka J Kruse F E Thierauch K H	2008	Invest Ophthalmol Vis Sci2008，49，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费